The addition of the antisense agent oblimersen to fludarabine and cyclophosphamide improved response to therapy and survival in patients with relapsed or refractory chronic lymphocytic leukemia. Medscape Medical News
Research that will affect clinical practice includes a study showing that zoledronic acid reduces relapse in early breast cancer and KRAS mutations predict which patients will respond to cetuximab. Medscape Medical News
In this Expert Interview, Lisa Carey, MD, discusses the biologic differences that underlie differences in breast tumor behavior and outcomes. Medscape Hematology-Oncology
Functional polymorphisms in the gene expressing epidermal growth factor receptor (EGFR) have opposite prognostic implications for male and female patients with metastatic colon cancer, new study findings indicate. Reuters Health Information
